slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 87,991-88,020
Pages 3,225
Rows per page 30
Component
87,991-88,020 of 96,741
24
The slide uses a chronological sequence to demonstrate management's effective handling of a major revenue threat.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
25
The slide uses a hub-and-spoke diagram to show the core Alkermes business and a separate branch for the oncology spin-off.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
29
The slide uses a table-like structure to compare four board members.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
31
Includes a specific quote from an ISS recommendation regarding majority voting standards.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
32
Uses a before-after framing to show how shareholder feedback led to specific governance improvements.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
35
This slide is part of a proxy contest defense, specifically attacking the credibility and suitability of the activist's nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
36
The slide uses a two-column layout to contrast the 'Process' of board composition with the 'Decision Making' regarding specific nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
37
The slide uses a red-themed table to highlight negative attributes of specific individuals.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
39
The slide uses a checkmark matrix to demonstrate board competency across five key areas: Neuroscience, Financial/Transactional, Commercial, Medical/R&D, and Global Business.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
40
This is a proxy fight slide comparing incumbent board members against challenger nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
41
The slide uses a sidebar callout to emphasize the Board's role in initiating the transformation.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
50
The slide uses a list of governance attributes on the left and three donut charts on the right to illustrate compensation design.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
04
The slide uses a circular graphic element to emphasize the 'revolution' in autoimmunity.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Why1 hit
11
The slide uses a geographic split between US and Global markets to track approval timelines.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a hub-and-spoke visual metaphor to link the clinical class to the specific biological targets.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
13
The slide uses a pyramid structure to represent market size, with smaller patient populations at the top and larger ones at the bottom.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
14
The slide uses a visual representation of an antibody to explain its 'sweeping' mechanism.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit
16
Includes a biological mechanism diagram on the left and a clinical trial roadmap on the right.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · RoadmapLoop · Quick Win Big Bet1 hit
18
The slide uses a network-style layout to show relationships between diverse entities in the biotech/pharma space.argenx SE | Investor Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · Roadmap1 hit
03
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Messages1 hit
05
argenx SE | Results Presentation Deck | 15 slidesargenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations Beat · Key Messages1 hit
12
The slide uses a two-tier layout separating US-specific approvals from other global regions.argenx SE | Results Presentation Deck | 15 slides · argenx
Conference presentation Investor relations 1 hit
08
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 1 hit
13
Uses a Venn diagram to define the 'HLS' (High Luxury Sport) segment.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 1 hit
06
The slide uses a combination of stacked bar charts for revenue composition and a horizontal bar chart for growth metrics.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
07
Includes a timeline of 5 years of Plenary Presentations.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
14
Includes Kaplan-Meier survival curve and 'number at risk' table.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
22
The slide outlines a clinical trial structure with six cohorts testing different combinations of Dato-DXd, pembrolizumab, and platinum-based chemotherapy.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
26
Includes spider plot (target lesion change over time) and waterfall plot (best percentage change).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
27
The slide uses a matrix-like layout to categorize clinical trials by disease stage and treatment line.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit